Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × gadobutrol × Clear all

NCT04910425 2025-10-21

PSMA-Targeted 18F-DCFPyL PET/MRI for the Detection of Prostate Cancer

Phase 2 Withdrawn

Prostatic Neoplasms